| 000 | 01393 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515144946.0 | ||
| 264 | 0 | _c20090225 | |
| 008 | 200902s 0 0 eng d | ||
| 022 | _a1476-5365 | ||
| 024 | 7 |
_a10.1038/bmt.2008.275 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBiffi, A | |
| 245 | 0 | 0 |
_aMetachromatic leukodystrophy: an overview of current and prospective treatments. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cOct 2008 |
||
| 300 |
_aS2-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBlood-Brain Barrier _xenzymology |
| 650 | 0 | 4 |
_aCerebroside-Sulfatase _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 |
_aGenetic Therapy _xtrends |
| 650 | 0 | 4 | _aGraft vs Host Disease |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xtrends |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukodystrophy, Metachromatic _xenzymology |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 700 | 1 | _aLucchini, G | |
| 700 | 1 | _aRovelli, A | |
| 700 | 1 | _aSessa, M | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 42 Suppl 2 _gp. S2-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bmt.2008.275 _zAvailable from publisher's website |
| 999 |
_c18440340 _d18440340 |
||